Skip to content

Multi center prospective real-world study of medicinal activated carbon particles for acute oral poisoning

Multi center prospective real-world study of medicinal activated carbon particles for acute oral poisoning

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500095531
Enrollment
Unknown
Registered
2025-01-08
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with oral poisoning, such as pesticide poisoning, insecticide/rodenticide poisoning, drug poisoning, plant toxin poisoning, disinfectant and other poisoning

Interventions

Sponsors

Suining Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Acute oral poisoning or drug overdose patients; 2.Age = 14 years old; 3.The patient or their guardian signs an informed consent form;

Exclusion criteria

Exclusion criteria: 1.Alcohols (such as ethanol, methanol, and diols, such as ethylene glycol), inorganic salts (such as sodium chloride), metals and their inorganic compounds (such as lithium, iron, or other heavy metals, such as lead or mercury), organic solvents (such as acetone, dimethyl sulfoxide, gasoline), acids and bases, cyanide poisoning; 2.Exposure to toxins that inhibit gastrointestinal motility (such as anticholinergic drugs, opioid drugs, etc.); 3.The patient has consciousness disorders, no swallowing reflex, and no airway protection; 4.Corrosion or bleeding of the gastrointestinal tract, damage or suspected perforation of the gastrointestinal tract; 5.recurrent vomiting; 6.Unable to obtain informed consent form;

Design outcomes

Primary

MeasureTime frame
Toxic blood drug concentration 1;Toxic blood drug concentration 2;Poisoning Severity Score;28 day clinical outcome;Blood purification;Blood biochemistry data 1;Blood biochemistry data 2;

Secondary

MeasureTime frame
hospital stay;Tracheal intubation and ventilator assisted ventilation;Intensive care treatment;Clinical basic data;

Countries

China

Contacts

Public ContactHu Jianping

Suining Central Hospital

175398908@qq.com+86 159 0840 8240

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026